GRAXOFIL Trademark

Trademark Overview

On Thursday, November 17, 2016, a trademark application was filed for GRAXOFIL with the United States Patent and Trademark Office. The USPTO has given the GRAXOFIL trademark a serial number of 87240794. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 2, 2021. This trademark is owned by Apotex Technologies Inc.. The GRAXOFIL trademark is filed in the Pharmaceutical Products category with the following description:

Biosimilar pharmaceutical preparation, namely, a granulocyte colony-stimulating factor analog used to stimulate the proliferation and differentiation of granulocytes for use with chemotherapy regimens to lessen the incidence of chemotherapy-induced neutropenia
graxofil

General Information

Serial Number87240794
Word MarkGRAXOFIL
Filing DateThursday, November 17, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 2, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2017

Trademark Statements

Goods and ServicesBiosimilar pharmaceutical preparation, namely, a granulocyte colony-stimulating factor analog used to stimulate the proliferation and differentiation of granulocytes for use with chemotherapy regimens to lessen the incidence of chemotherapy-induced neutropenia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 23, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAccord Biopharma, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameApotex Technologies Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9L1T9
CA
Party NameApotex Technologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9L1T9
CA

Trademark Events

Event DateEvent Description
Monday, August 2, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 2, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, January 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 14, 2021EXTENSION 1 GRANTED
Wednesday, December 30, 2020EXTENSION 1 FILED
Thursday, January 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 30, 2020TEAS EXTENSION RECEIVED
Tuesday, December 29, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 29, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, December 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 30, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, May 16, 2020TTAB RELEASE CASE TO TRADEMARKS
Saturday, May 16, 2020OPPOSITION TERMINATED NO. 999999
Saturday, May 16, 2020OPPOSITION DISMISSED NO. 999999
Wednesday, April 15, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 18, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 3, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, November 10, 2017OPPOSITION INSTITUTED NO. 999999
Wednesday, June 14, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 16, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 3, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 3, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 28, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, February 28, 2017PRIORITY ACTION E-MAILED
Tuesday, February 28, 2017PRIORITY ACTION WRITTEN
Thursday, February 23, 2017ASSIGNED TO EXAMINER
Wednesday, November 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 21, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

graxofil chemotherapy granulocytes differentiation proliferation regimens lessen neutropenia induced incidence stimulate